Showing results (101-110 of 413) with videos related to
Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|March 8, 2011
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosisAlexander R Moschen, Teresa Fritz, Andrew D Clouston, et al.Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.Gut Microbes|October 10, 2023
Microbial-host-isozyme: unveiling a new era in microbiome-host interactionLei Miao, Herbert Tilg, Ming-Hua ZhengCurrent Diabetes Reports|April 3, 2020
Exocrine Pancreatic Insufficiency in Type 1 and Type 2 DiabetesBernhard Radlinger, Gabriele Ramoser, Susanne KaserWiener Klinische Wochenschrift|April 8, 2016
[Autoimmune diseases in type 1 diabetes]Monika Lechleitner, Friedrich Hoppichler, Susanne KaserThe Lancet. Gastroenterology & Hepatology|May 7, 2021
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approachGiovanni Targher, Herbert Tilg, Christopher D ByrneGut|April 24, 2020
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implicationsGiovanni Targher, Christopher D Byrne, Herbert TilgHepatology (Baltimore, Md.)|April 14, 2023
Therapeutic modulation of the liver immune microenvironmentHerbert Tilg, Timon E Adolph, Frank TackeThe Lancet. Gastroenterology & Hepatology|August 19, 2023
NASH drug treatment development: challenges and lessonsHerbert Tilg, Christopher D Byrne, Giovanni TargherCell Metabolism|October 8, 2022
Gut-liver axis: Pathophysiological concepts and clinical implicationsHerbert Tilg, Timon E Adolph, Michael TraunerPageof 42